 REDWOOD CITY, CA ACCESSWIRE August 16, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease PAD, today announced presentations featuring the Companys Lumivascular, OCT-guided, technologies at the annual AMP Amputation Prevention Symposium conference occurring last week. AMP focuses on education and technologies for treating critical limb ischemia CLI, an advanced stage of PAD, in patients facing a life-altering amputation. 